Attitude thérapeutique face aux nouvelles céphalosporines = Therapeutic attitude with new cephalosporinsBERGERON, M. G.Union médicale du Canada. 1984, Vol 113, Num 12, pp 1041-1048, issn 0041-6959Article

Therapeutic potential of high renal levels of aminoglycosides in pyelonephritisBERGERON, M. G.Journal of antimicrobial chemotherapy (Print). 1985, Vol 15, Num 1, pp 4-8, issn 0305-7453Article

Genetic tools for the simultaneous identification of bacterial species and their antibiotic resistance genes : impact on clinical practiceBERGERON, M. G.International journal of antimicrobial agents. 2000, Vol 16, Num 1, pp 1-3, issn 0924-8579Article

Liposomes as drug delivery system : A strategic approach for the treatment of HIV infectionDESORMEAUX, A; BERGERON, M. G.Journal of drug targeting. 1998, Vol 6, Num 1, pp 1-15, issn 1061-186XArticle

Targeting HIV with liposome-encapsulated antiviralsDESORMEAUX, A; BERGERON, M. G.Zentralblatt für Bakteriologie. 1995, Vol 282, Num 3, pp 225-231, issn 0934-8840Article

Pharmacodynamic interaction between RP 59500 and gram-positive bacteria infecting fibrin clotsTURCOTTE, A; BERGERON, M. G.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 10, pp 2211-2215, issn 0066-4804Article

Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothinBERGERON, M. G; BERGERON, Y.Antimicrobial agents and chemotherapy. 1986, Vol 29, Num 1, pp 7-12, issn 0066-4804Article

Penetration of cefixime into fibrin clots and in vivo efficacy against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureusBERGERON, M. G; TURCOTTE, A.Antimicrobial agents and chemotherapy. 1986, Vol 30, Num 6, pp 913-916, issn 0066-4804Article

Preventing antibiotic resistance using rapid DNA-based diagnostic testsBERGERON, M. G; OUELLETTE, M.Infection control and hospital epidemiology. 1998, Vol 19, Num 8, pp 560-564, issn 0899-823XConference Paper

Pathogenic factors in aminoglycoside-induced nephrotoxicityKACEW, S; BERGERON, M. G.Toxicology letters. 1990, Vol 51, Num 3, pp 241-259, issn 0378-4274Article

Le diagnostic des maladies infectieuses en une heure : une révolution nécessaire = Bacterial identification in less than an hour, a necessary revolutionBERGERON, M. G; OUELLETTE, M.MS. Médecine sciences. 1997, Vol 13, Num 8-9, pp 998-1001, issn 0767-0974Article

Benefit from high intrarenal levels of gentamicin in the treatment of Escherichia coli pyelonephritisBERGERON, M. G; MAROIS, Y.Kidney international. 1986, Vol 30, Num 4, pp 481-487, issn 0085-2538Article

Preventing antibiotic resistance through rapid genotypic identification of bacteria and of their antibiotic resistance genes in the clinical microbiology laboratoryBERGERON, M. G; OUELLETTE, M.Journal of clinical microbiology (Print). 1998, Vol 36, Num 8, pp 2169-2172, issn 0095-1137Article

What preclinical data are needed to justify once-daily therapy ?BERGERON, M. G.Journal of clinical pharmacology. 1992, Vol 32, Num 8, pp 698-705, issn 0091-2700Conference Paper

Diagnosing infections—current and anticipated technologies for point-of-care diagnostics and home-based testing : Point-of-care: the XXIst century microbiologyBISSONNETTE, L; BERGERON, M. G.Clinical microbiology and infection. 2010, Vol 16, Num 8, pp 1044-1053, issn 1198-743X, 10 p.Article

Principes pharmacologiques du traitement de la pyélonéphrite : distribution, efficacité et toxicité rénale des antibiotiques = Pharmacologic principles of pyelonephritis treatment. Distribution, efficiency and renal toxicity of antibioticsBEAUCHAMP, D; BERGERON, M. G.MS. Médecine sciences. 1997, Vol 13, Num 8-9, pp 942-951, issn 0767-0974Article

Influence of three modes of administration on the penetration of latamoxef into interstitial fluid and fibrin clots and its in-vivo activity against Haemophilus influenzaeBERGERON, M. G; SIMARD, P.Journal of antimicrobial chemotherapy (Print). 1986, Vol 17, Num 6, pp 775-784, issn 0305-7453Article

False-resistance of Streptococcus faecalis and Pseudomonas maltophilia to norfloxacin by disc diffusion susceptibility testingGRIMARD, D; BERGERON, M. G.Journal of antimicrobial chemotherapy (Print). 1985, Vol 16, Num 1, pp 132-133, issn 0305-7453Article

Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritisKABORE, A. F; SIMARD, M; BERGERON, M. G et al.The Journal of infectious diseases. 1999, Vol 179, Num 5, pp 1162-1172, issn 0022-1899Article

Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9GAGNE, N; CORMIER, H; OMAR, R. F et al.Sexually transmitted diseases. 1999, Vol 26, Num 3, pp 177-183, issn 0148-5717Article

Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patientsGILBERT, C; HANDFIELD, J; TOMA, E et al.AIDS (London). 1998, Vol 12, Num 2, pp 125-129, issn 0269-9370Article

Lymphoid tissues targeting of liposome-encapsulated 2',3'-dideoxyinosineHARVIE, P; DESORMEAUX, A; CAGNE, N et al.AIDS (London). 1995, Vol 9, Num 7, pp 701-707, issn 0269-9370Article

Uptake and binding of liposomal 2',3'-dideoxycytidine by RAW 264.7 cells : a three-step processMAKABI-PANZU, B; LESSARD, C; BEAUCHAMP, D et al.Journal of acquired immune deficiency syndromes and human retrovirology. 1995, Vol 8, Num 3, pp 227-235, issn 1077-9450Article

Treatment of pyelonephritis in adultsBERGERON, M. G.The Medical clinics of North America. 1995, Vol 79, Num 3, pp 619-649, issn 0025-7125Article

Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgeryBERGERON, M. G; SAGINUR, R; DESAULNIERS, D et al.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 9, pp 1699-1702, issn 0066-4804, 4 p.Article